홈 / 슈퍼인베스터 / 인게이지드 캐피털

인게이지드 캐피털

ENGAGED · CIK 0001559771 · 2016-03-31 기준 · 원본 신고 1건 (최근 2016-05-16) · EDGAR 원문

2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 CSV JSON
평가액
$296.3M
보유 종목
12
상위 10 비중
97.8%

보유 종목

12종목
종목 보유수량 평가액 ▼ 신고가 현재가 ±신고 52주 비중
OUTERWALL INC
690070107 · 2015-12-31부터 · +1.2%
2,431,170 $89.93M $36.99 - - - 30.4%
BENCHMARK ELECTRS INC
BHE · 08160H101 · 2015-03-31부터 · -4.1%
2,428,221 $55.97M $23.05 $63.03 +173.5% $42.15 – $98.67 18.9%
ROVI CORP
779376102 · 2013-12-31부터 · +4.2%
2,250,000 $46.15M $20.51 - - - 15.6%
JAMBA INC
47023A309 · 2014-06-30부터 · +2.1%
1,830,767 $22.63M $12.36 - - - 7.6%
MEDIFAST INC
MED · 58470H101 · 2014-03-31부터 · +3.8%
737,465 $22.26M $30.19 $12.97 -57.0% $9.45 – $13.37 7.5%
MAGNACHIP SEMICONDUCTOR CORP
MX · 55933J203 · 2015-06-30부터 · -29.5%
3,852,974 $20.96M $5.44 $2.50 -54.0% $2.05 – $8.93 7.1%
TRIMAS CORP
TRS · 896215209 · 2014-09-30부터 · -28.0%
679,067 $11.9M $17.52 $37.57 +114.4% $31.24 – $45.03 4.0%
HEARTWARE INTL INC
422368100 · 2015-09-30부터 · -39.9%
240,750 $7.564M $31.42 - - - 2.6%
ISHARES TR
IWM · 464287655 · 2016-03-31부터 · 0.0%
56,789 $6.283M $110.64 $277.54 +150.9% $229.11 – $305.09 2.1%
BIODELIVERY SCIENCES INTL IN
09060J106 · 2016-03-31부터 · 0.0%
1,876,550 $6.061M $3.23 - - - 2.0%
LIBBEY INC
529898108 · 2015-12-31부터 · -12.8%
270,064 $5.023M $18.60 - - - 1.7%
AMAG PHARMACEUTICALS INC
AMAG · 00163U106 · 2015-12-31부터 · -22.5%
65,916 $1.542M $23.39 - - - 0.5%

12개 신고 항목을 12개 CUSIP으로 합산했습니다. 위임 운용사별로 나뉜 항목은 합산합니다.

13F는 롱 포지션만(롱옵션 포함, 숏·현금 제외)이며 분기말 기준입니다.